GESTATIONAL TROPHOBLASTIC DISEASE

Authors

  • Rodrigo Durón González Médico General. Clínica Unimed
  • Pamela Bolaños Morera Médico General. Clínica Integral Cordero

Keywords:

Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, Hidatidiform mole, Trofoblastic Tumors.

Abstract

The gestational trophoblastic disease englobes a set of neoplastic pathologies and pathologies with malignant potential, which can be acquired after gestation. Even though these tumors include less than 1% of gynecological tumors, they represent a threat to the life of women in reproductive age. It is important that physicians understand its etiology, natural evolution and control. If it is diagnosed on time and treated appropriately according to its risk and prognosis criteria, there’s a high healing potential including the ability of preserving reproductive function.

References

1. Vitthalrao, S., Aher, V., Gadhiya, S., & Sunil, S. (August 2017). Gestational Trophoblastic Disease - Clinicopathological Study at Tertiary Care Hospital. Journal of Clinical and Diagnostic Research,11 (8), 27-30.

2. Seckl, M., Sebire, N., & Berkowitz, R. (August 2010). Gestational Trophoblastic Disease. The Lancet , 376, 717-729.

3. Devita, V., Lawrence, T., & Rosenberg, S. (2015). Cancer: Principles & Practice of Oncology (10th Edition). Wolters Kluwer Health. 1069.

4. Lurain, J. (December 2010). Gestational Trophoblastic Disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. American Journal of Obstetrics & Gynecology , 203 (6), 531-539.

5. Monchek, R., & Wiedaseck, S. (May 2012). Gestational Trophoblastic Disease: An Overview. Journal of Midwifery & Women's Health , 57 (3), 255-259.

6. Hui, P., Buza, N., Murphy, K., & Ronnette, B. (January 2017). Hydatidiform Moles: Genetic Basis and Precision Diagnosis . Annual Review of Pathology Mechanisms od Disease , 12, 449-485.

7. Osborne, R., & Dodge, J. (June 2012). Gestational Trophoblastic Neoplasia. Obstetrics and Gynecology Clinics of North America , 39 (2), 195-212.

8. Mao, T., Kurman, R., Huang, C., Lin, M., & Shih, I. (November 2007). Inmonohistochemistry of Choriocarcinoma, An Aid in Differential Diagnosis and in Elucidating Pathogenesis. The American Journal of Surgical Pathology , 31 (11), 1726-1732.

9. Horowitz, N., Goldstein, D., & Berkowitz, R. (January 2017). Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors: biology, natural history and treatment modalities. Gynecologic Oncology , 144 (1), 208-214.

10. Ming, I. (July 2007). Gestational Trophoblastic Neoplasia-Pathogenesis and Potential Therapeutic Targets. The Lancet Oncology , 8, 642-650.

11. Melamed, A., et al. (October 2016). Effect of Race/Ethnicity on Risk of Complete and Partial Molar Pregnancy after Adjustment for Age. Gynecologic Oncology , 143 (1), 73-76.

12. Shaaban, A., et al. (March-April 2017). Gestational Trophoblastic Disease: Clinical and Imaging Features . RadioGraphics: The journal of continuing medical education in radiology , 37 (2), 681-700.

13. Goldstein, D., & Berkowitz, R. (February 2012). Current Management of Gestational Trophoblastic Neoplasia . Hematology Oncology Clinics of North America , 26 (1), 111-131.

14. El-Helw, L., & Hancock, B. (August 2007). Treatment of Metastasic Gestational Trophoblastic Neoplasia. The Lancet Oncology , 8, 715-724.

15. Gueye, M., et al. (2016). Diagnosis, Treatment and Outcome of Gestational Trophoblastic Neoplasia in a Low Resource Income Country. International Journal of MCH and AIDS , 5 (2), 112-118.

Published

2020-11-13

How to Cite